Evidence map›Paper›PMID 15951393›Full record

Trial reportHeart (British Cardiac Society)2006

Favourable long term prognosis in stable angina pectoris: an extended follow up of the angina prognosis study in Stockholm (APSIS).

P Hjemdahl, S V Eriksson, C Held, L Forslund, P Näsman, N Rehnqvist

Open access · bronzeAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Heart (British Cardiac Society), 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
13.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 62 citations in OpenAlex.

  1. Beta-blockers for hypertension.The Cochrane database of systematic reviews · 2017
    Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Consensus Document ANMCO/ANCE/ARCA/GICR-IACPR/GISE/SICOA: Long-term Antiplatelet Therapy in Patients with Coronary Artery Disease.European heart journal supplements : journal of the European Society of Cardiology · 2018
    Article
  8. ANMCO/GICR-IACPR/SICI-GISE Consensus Document: the clinical management of chronic ischaemic cardiomyopathy.European heart journal supplements : journal of the European Society of Cardiology · 2017
    Article
  9. Review
  10. Review
  11. Observational
  12. Article
  13. Article
  14. Article
  15. Short-term effects of ivabradine in patients with chronic stable ischemic heart disease.Heart views : the official journal of the Gulf Heart Association · 2013
    Article
  16. Therapy for stable angina in women.P & T : a peer-reviewed journal for formulary management · 2012
    Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

P HjemdahlDepartment of Medicine, Karolinska University Hospital (Solna), Stockholm, Sweden. Paul.Hjemdahl@medks.ki.se
S V Eriksson
C Held
L Forslund
P Näsman
N Rehnqvist
Karolinska University Hospital · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo evaluate the long term prognosis of patients with stable angina pectoris.

designRegistry based follow up (median 9.1 years) of patients participating in the APSIS (angina prognosis study in Stockholm), which was a double blind, single centre trial of antianginal drug treatment. PATIENTS: 809 patients (31% women) with stable angina pectoris < 70 (mean (SD) 59 (7) years at inclusion) and an age and sex matched reference population from the same catchment area.

interventionsDouble blind treatment with metoprolol or verapamil during 3.4 years (median), followed by referral for usual care with open treatment.

main outcome measuresCardiovascular (CV) death and non-fatal myocardial infarction (MI) in the APSIS cohort and total mortality in comparison with reference subjects.

results123 patients died (41 MI, 36 other CV causes) and 72 had non-fatal MI. Mortality (19% v 6%, p < 0.001) and fatal MI (6.6% v 1.6%, p < 0.001) were increased among male compared with female patients. Diabetes, previous MI, hypertension, and male sex independently predicted CV mortality (p < 0.001). Diabetes greatly increased the risk in a small subgroup of female patients. Male patients had higher mortality than men in the reference population during the first three years (cumulative absolute difference 3.8%) but apparently not thereafter. Female patients had similar mortality to women in the reference population throughout the 9.1 years of observation.

conclusionsFemale patients with stable angina had similar mortality to matched female reference subjects but male patients had an increased risk. Diabetes, previous MI, hypertension, and male sex were strong risk factors for CV death or MI.

Indexed as

Adrenergic beta-AntagonistsAngina PectorisCalcium Channel BlockersDeath, Sudden, CardiacDiabetic AngiopathiesEpidemiologic FactorsFemaleHumansHypertensionMaleMetoprololMiddle AgedMyocardial InfarctionPrognosisSex FactorsSwedenAdrenergic beta-AntagonistsCalcium Channel BlockersMetoprololVerapamil

Identifiers

PMID15951393
PMCPMC1860751
OpenAlexW2126829903

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.